| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lapatinib | UHNBreast | pan-cancer | AAC | -0.39 | 0.2 |
| mRNA | MK-0752 | CTRPv2 | pan-cancer | AAC | 0.052 | 0.2 |
| mRNA | BRD-A71883111 | CTRPv2 | pan-cancer | AAC | 0.049 | 0.2 |
| mRNA | LRRK2-IN-1 | CTRPv2 | pan-cancer | AAC | 0.051 | 0.2 |
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | -0.065 | 0.2 |
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | -0.069 | 0.2 |
| mRNA | salermide | CTRPv2 | pan-cancer | AAC | -0.063 | 0.2 |
| mRNA | dacarbazine | CTRPv2 | pan-cancer | AAC | -0.042 | 0.2 |
| mRNA | quizartinib | CTRPv2 | pan-cancer | AAC | 0.049 | 0.2 |
| mRNA | triptolide | CTRPv2 | pan-cancer | AAC | -0.046 | 0.2 |